Researcher
Lukasz Bialkowski
- Keywords:Medicine
Affiliations
- Basic (bio-) Medical Sciences (Department)
Member
From1 Jan 2017 → 14 Jul 2017 - Faculty of Medicine and Pharmacy (Faculty)
Member
From9 Oct 2015 → 16 Jan 2018 - Basic (bio-) Medical Sciences (Department)
Member
From1 Jan 2014 → 14 Jul 2017 - Physiology (Department)
Member
From1 Oct 2011 → 31 Dec 2013 - Laboratory of Molecullar and Cellular Therapy (Research group)
Member
From6 Feb 2010 → 14 Jul 2017
Publications
1 - 7 of 7
- Immune checkpoint blockade combined with IL-6 and TGF-β inhibition improves the therapeutic outcome of mRNA-based immunotherapy(2018)
Authors: Lukasz Bialkowski, Kevin Van der Jeught, Sanne Bevers, Patrick Tjok Joe, Dries Renmans, Carlo Heirman, Joeri L Aerts, Kris Thielemans
Pages: 686-698 - Combination therapy for a durable tumor rejection(2018)
Authors: Lukasz Bialkowski, Kris Thielemans, Joeri L Aerts
- Adjuvant-Enhanced mRNA Vaccines(2017)
Authors: Lukasz Bialkowski, Dries Renmans, Alexia Van Weijnen
Pages: 179-191 - Intratumoral Delivery of TriMix mRNA Results in T-cell Activation by Cross-Presenting Dendritic Cells(2016)
Authors: Sandra Van Lint, Dries Renmans, Katrijn Broos, Lode Goethals, Sarah Maenhout, Daphné Benteyn, Cleo Goyvaerts, Stephanie Du Four, Kevin Van der Jeught, Lukasz Bialkowski, et al.
Pages: 146-156 - Intralymphatic mRNA vaccine induces CD8 T-cell responses that inhibit the growth of mucosally located tumours(2016)
Authors: Lukasz Bialkowski, Alexia Van Weijnen, Kevin Van der Jeught, Dries Renmans, Lidia Daszkiewicz, Carlo Heirman, Geert Stangé, Karine Breckpot, Joeri L Aerts, Kris Thielemans
Pages: 1-15 - Targeting the tumor microenvironment to enhance antitumor immune responses.(2015)
Authors: Lukasz Bialkowski, Lidia Daszkiewicz, Dries Renmans
Pages: 1359-1381 - Intratumoral administration of mRNA encoding a fusokine consisting of IFN-β and the ectodomain of the TGF-β receptor II potentiates antitumor immunity(2014)
Authors: Patrick Tjok Joe, Lukasz Bialkowski, Lidia Daszkiewicz, Therese Liechtenstein, David Escors
Pages: 10100-10113